DK3201203T3 - Krystallinsk form af 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indol-3-carboxamid - Google Patents
Krystallinsk form af 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indol-3-carboxamid Download PDFInfo
- Publication number
- DK3201203T3 DK3201203T3 DK15778162.6T DK15778162T DK3201203T3 DK 3201203 T3 DK3201203 T3 DK 3201203T3 DK 15778162 T DK15778162 T DK 15778162T DK 3201203 T3 DK3201203 T3 DK 3201203T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyl
- nonan
- azabicyclo
- indol
- pyrazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462056982P | 2014-09-29 | 2014-09-29 | |
PCT/US2015/052806 WO2016053947A1 (en) | 2014-09-29 | 2015-09-29 | Crystalline form of 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indole-3-carboxamide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3201203T3 true DK3201203T3 (da) | 2021-08-23 |
Family
ID=54289137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15778162.6T DK3201203T3 (da) | 2014-09-29 | 2015-09-29 | Krystallinsk form af 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indol-3-carboxamid |
Country Status (12)
Country | Link |
---|---|
US (1) | US10329306B2 (da) |
EP (1) | EP3201203B1 (da) |
JP (2) | JP7055017B2 (da) |
CN (1) | CN106795172B (da) |
CA (1) | CA2962429C (da) |
DK (1) | DK3201203T3 (da) |
ES (1) | ES2883295T3 (da) |
HU (1) | HUE055175T2 (da) |
MA (1) | MA40771B1 (da) |
PL (1) | PL3201203T3 (da) |
PT (1) | PT3201203T (da) |
WO (1) | WO2016053947A1 (da) |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
FR2531083B1 (fr) | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
JPS5936675A (ja) | 1982-07-13 | 1984-02-28 | サンド・アクチエンゲゼルシヤフト | 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド |
GB8510752D0 (en) | 1985-04-27 | 1985-06-05 | Beecham Group Plc | Compounds |
EP0498466B1 (en) | 1985-04-27 | 2002-07-24 | F. Hoffmann-La Roche Ag | Indazole-3-carboxamide and -3-carboxylic acid derivatives |
US4910193A (en) | 1985-12-16 | 1990-03-20 | Sandoz Ltd. | Treatment of gastrointestinal disorders |
DE3722069A1 (de) | 1986-08-21 | 1988-02-25 | Toyoda Gosei Kk | Signalhornschaltvorrichtung fuer ein steuerrad |
WO1988003801A1 (en) | 1986-11-21 | 1988-06-02 | Glaxo Group Limited | Medicaments for treatment or prevention of withdrawal syndrome |
IT1226389B (it) | 1988-07-12 | 1991-01-15 | Angeli Inst Spa | Nuovi derivati ammidinici e guanidinici |
GB8829079D0 (en) | 1988-12-13 | 1989-01-25 | Beecham Group Plc | Novel compounds |
JPH0421681A (ja) | 1990-05-14 | 1992-01-24 | Fujisawa Pharmaceut Co Ltd | ピロロピリジン誘導体 |
JP3251954B2 (ja) | 1990-07-31 | 2002-01-28 | 日清ファルマ株式会社 | アザビシクロ誘導体 |
US5187166A (en) | 1990-07-31 | 1993-02-16 | Nisshin Flour Milling Co., Ltd. | Azabicyclo derivatives and their use as antiemetics |
HU211081B (en) | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5149962A (en) | 1991-06-03 | 1992-09-22 | Simmonds Precision Products, Inc. | Proximity detector using faraday effect and bidirectional transmission |
US5344831A (en) | 1992-01-31 | 1994-09-06 | Nisshin Flour Milling Co., Ltd. | Diazabicyclo derivatives |
GB9216154D0 (en) | 1992-07-30 | 1992-09-09 | Glaxo Group Ltd | Chemical compounds |
GB9406857D0 (en) | 1994-04-07 | 1994-06-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
WO1996012722A1 (fr) | 1994-10-20 | 1996-05-02 | Nisshin Flour Milling Co., Ltd. | Agoniste des recepteurs 5-ht¿4? |
CA2160420A1 (en) | 1994-10-20 | 1996-04-21 | Haruhiko Kikuchi | 5-ht4 receptor agonists |
JP3904254B2 (ja) | 1994-10-20 | 2007-04-11 | 株式会社日清製粉グループ本社 | 5−ht4受容体作動薬 |
WO2000044743A1 (fr) | 1999-01-28 | 2000-08-03 | Nippon Shinyaku Co., Ltd. | Derives d'amides et compositions de medicaments |
WO2001043746A1 (fr) | 1999-12-14 | 2001-06-21 | Nippon Shinyaku Co., Ltd. | Composition medicinale |
BR0212613A (pt) | 2001-09-19 | 2004-08-31 | Pharmacia Corp | Compostos de indazol substituìdos para o tratamento de inflamação |
US20040038958A1 (en) | 2002-07-11 | 2004-02-26 | Chris Rundfeldt | Topical treatment of skin diseases |
ES2405594T3 (es) | 2002-09-25 | 2013-05-31 | Memory Pharmaceuticals Corporation | Idazoles, benzotiazoles y benzisotiazoles, y preparación y usos de los mismos |
CN100353946C (zh) | 2003-01-13 | 2007-12-12 | 戴诺吉药品有限公司 | 治疗功能性肠病的方法 |
EP1615698B1 (en) | 2003-04-11 | 2010-09-29 | High Point Pharmaceuticals, LLC | New amide derivatives and pharmaceutical use thereof |
UA93348C2 (ru) | 2004-03-25 | 2011-02-10 | Меморі Фармас'Ютікалз Корпорейшн | Индазолы, бензотиазолы, бензоизотиазолы, их получение и применение |
MXPA06010852A (es) | 2004-03-25 | 2007-01-16 | Memory Pharm Corp | Indazoles, benzotiazoles, benzoisotiazoles, bencisoxazoles y preparacion y usos de los mismos. |
CA2594773A1 (en) | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
CA2622677A1 (en) | 2005-09-23 | 2007-04-05 | Richard Schumacher | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
CN101460458A (zh) | 2006-02-15 | 2009-06-17 | 阿勒根公司 | 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物 |
WO2007095561A2 (en) | 2006-02-15 | 2007-08-23 | Allergan, Inc. | Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
KR101288781B1 (ko) | 2006-06-28 | 2013-07-22 | 암젠 인크 | 글리신 수송자-1 억제제 |
US7960569B2 (en) | 2006-10-17 | 2011-06-14 | Bristol-Myers Squibb Company | Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
US20100204282A1 (en) | 2007-02-05 | 2010-08-12 | Hutchinson John H | Reverse indoles as 5-lipoxygenase-activating protein (FLAP) inhibitors |
EP2134683A2 (en) | 2007-02-12 | 2009-12-23 | Intermune, Inc. | Novel inhibitors hepatitis c virus replication |
JP2010535816A (ja) | 2007-08-10 | 2010-11-25 | ハー・ルンドベック・アクチエゼルスカベット | ヘテロアリールアミド類似体 |
WO2009108551A2 (en) | 2008-02-25 | 2009-09-03 | H. Lundbeck A/S | Heteroaryl amide analogues |
US8124600B2 (en) | 2008-05-29 | 2012-02-28 | Albany Molecular Research, Inc. | 5-HT3 receptor modulators, methods of making, and use thereof |
TWI429628B (zh) | 2010-03-29 | 2014-03-11 | Univ Taipei Medical | 吲哚基或吲哚啉基羥肟酸化合物 |
WO2011153553A2 (en) | 2010-06-04 | 2011-12-08 | The Regents Of The University Of California | Methods and compositions for kinase inhibition |
JOP20130213B1 (ar) | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
-
2015
- 2015-09-29 PL PL15778162T patent/PL3201203T3/pl unknown
- 2015-09-29 CN CN201580052611.3A patent/CN106795172B/zh active Active
- 2015-09-29 MA MA40771A patent/MA40771B1/fr unknown
- 2015-09-29 PT PT157781626T patent/PT3201203T/pt unknown
- 2015-09-29 CA CA2962429A patent/CA2962429C/en active Active
- 2015-09-29 ES ES15778162T patent/ES2883295T3/es active Active
- 2015-09-29 EP EP15778162.6A patent/EP3201203B1/en active Active
- 2015-09-29 WO PCT/US2015/052806 patent/WO2016053947A1/en active Application Filing
- 2015-09-29 JP JP2017516693A patent/JP7055017B2/ja active Active
- 2015-09-29 US US15/515,263 patent/US10329306B2/en active Active
- 2015-09-29 HU HUE15778162A patent/HUE055175T2/hu unknown
- 2015-09-29 DK DK15778162.6T patent/DK3201203T3/da active
-
2021
- 2021-11-19 JP JP2021188428A patent/JP2022036978A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
PT3201203T (pt) | 2021-08-09 |
JP7055017B2 (ja) | 2022-04-15 |
CA2962429A1 (en) | 2016-04-07 |
US10329306B2 (en) | 2019-06-25 |
EP3201203B1 (en) | 2021-05-19 |
WO2016053947A1 (en) | 2016-04-07 |
PL3201203T3 (pl) | 2021-11-22 |
EP3201203A1 (en) | 2017-08-09 |
HUE055175T2 (hu) | 2021-11-29 |
US20170233406A1 (en) | 2017-08-17 |
CN106795172A (zh) | 2017-05-31 |
CN106795172B (zh) | 2020-07-28 |
JP2022036978A (ja) | 2022-03-08 |
ES2883295T3 (es) | 2021-12-07 |
CA2962429C (en) | 2023-01-03 |
JP2017529379A (ja) | 2017-10-05 |
MA40771B1 (fr) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3230281T3 (da) | 1,3-thiazol-2-yl-substituerede benzamider | |
DK3303348T3 (da) | Naphthyridinforbindelser som JAK-kinaseinhibitorer | |
FIC20240025I1 (fi) | Momelotinibi, mukaanlukien momelotinibidihydrokloridimonohydraatti | |
DK3139981T3 (da) | Forstøver | |
DK3220989T3 (da) | Intranasal administration | |
DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
DK3256462T3 (da) | Substituerede 2-thioimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
DK3139984T3 (da) | Forstøver | |
DK3105320T3 (da) | Syntetisk nethinde | |
DK3186227T3 (da) | Nye sulfonylaminobenzamid-forbindelser som anthelmintika | |
EP3170932A4 (en) | Stitch structure | |
IL248027B (en) | A new use of n,n-bis-2-mercaptoethyl isophthalamide | |
DK3201203T3 (da) | Krystallinsk form af 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indol-3-carboxamid | |
DK3448845T3 (da) | Substituerede 2-alkylimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
ITUA20164343A1 (it) | Miscela erbicida | |
UA31288S (uk) | Пружина меблева | |
UA31287S (uk) | Пружина меблева | |
TH1601000900A (th) | สารประกอบซึ่งถูกแทนที่ด้วยควิโนลีนชนิดใหม่ | |
TH1601003398A (th) | องค์ประกอบทางเภสัชกรรมซึ่งประกอบรวมด้วยไดเมธิลฟูมาเรต | |
TH1601003066A (th) | สารผสมเคลือบ | |
ES1143933Y (es) | Atomizador | |
TH1401006469B (th) | หัวจ่ายน้ำมัน | |
TH1501000572B (th) | สารผสมรวม | |
TH1601001857A (th) | สารผสมสำหรับเคลือบชนิดใหม่ | |
TH1601007802B (th) | ผลิตภัณฑ์ซึมซับ |